Volitionrx (VNRX) Accounts Payables (2011 - 2025)

Volitionrx has reported Accounts Payables for 11 years, with the latest figure at $2.9 million in Q4 2025.

• For the quarter ending Q4 2025, Accounts Payables rose 5.52% year-over-year to $2.9 million; the trailing twelve-month figure through Dec 2025 stood at $2.9 million (up 5.52% YoY), and the FY2025 full-year result was $2.9 million, up 5.52% from the prior year.
• Accounts Payables for Q4 2025 stood at $2.9 million, down from $3.1 million in the prior quarter.
• The five-year high for Accounts Payables was $3.5 million in Q1 2024, with the low at $1.1 million in Q2 2021.
• Historically, Accounts Payables has averaged $2.7 million across 5 years, with a median of $2.9 million in 2025.
• Annual changes were most pronounced in 2022 — Accounts Payables jumped 140.24% — and 2025, when it dropped 29.78%.
• Volitionrx's Accounts Payables stood at $1.5 million in 2021, then soared by 97.28% to $3.0 million in 2022, then rose by 5.53% to $3.2 million in 2023, then decreased by 13.86% to $2.8 million in 2024, then grew by 5.52% to $2.9 million in 2025.
• The last three Accounts Payables figures came in at $2.9 million (Q4 2025), $3.1 million (Q3 2025), and $2.4 million (Q2 2025), per Business Quant data.